Main Article Content
PRACTICE POINTS: Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa
Abstract
[World Health Organization/UNAIDS] Geneva, October, 2000.
Prophylactic treatment with cotrimoxazole can potentially enhance essential HIV care programmes in Africa by preventing several secondary bacterial and parasitic infections in people living with HIV/AIDS (PLHA). This intervention has been discussed at a UNAIDS/WHO consultation held in Harare, Zimbabwe on 29-31 March 2000. In view of the urgent need to preserve the health and well-being of HIV-infected individuals in Africa, where the HIV epidemic has its largest impact, WHO and the UNAIDS secretariat endorse the following as provisional recommendations: [ given in full in journal]
African Health Sciences 2001; 1(1): 30-31.
Prophylactic treatment with cotrimoxazole can potentially enhance essential HIV care programmes in Africa by preventing several secondary bacterial and parasitic infections in people living with HIV/AIDS (PLHA). This intervention has been discussed at a UNAIDS/WHO consultation held in Harare, Zimbabwe on 29-31 March 2000. In view of the urgent need to preserve the health and well-being of HIV-infected individuals in Africa, where the HIV epidemic has its largest impact, WHO and the UNAIDS secretariat endorse the following as provisional recommendations: [ given in full in journal]
African Health Sciences 2001; 1(1): 30-31.